Leverage Shares 100% TSLA AND 100% SPCX Daily ETF (NQ:ELOL)Price and VolumeDetailed Quote
Performance
52-Week Range
19.7% below 52-week high
23.02
14.8452W Low
28.6852W High
1 Week
15.1% below 1-week high
23.611W Low
27.111W High
Leverage Shares 100% TSLA AND 100% SPCX Daily ETF (ELOL) traded between $14.84 and $28.68 over the past 52 weeks and last traded at $23.02, 19.7% below its 52-week high. Over the past week it ranged between $23.61 and $27.11.
Past 12 Months
1W
-$2.66
1M
-$0.02
3M
+$7.53
6M
+$7.53
YTD
+$7.53
1Y
+$7.53
ELOL was +48.6% over the past year, +48.6% over six months, +48.6% year to date, -10.4% in the last week.
12 Months vs Market
ELOL
DIA
SPY
QQQ
IWM
Over the past 12 months ELOL returned +48.6% versus DIA (Dow) +12.8%, SPY (S&P 500) +16.7%, QQQ (Nasdaq 100) +21.8% and IWM (Russell 2000) +10.9%.
Volume & Liquidity
0.69× 3-mo avg
Today 10,966
3-mo avg 15.8K
1W
1M
3M
6M
YTD
1Y
ELOL most recently traded 10,966 shares against a 3-month average daily volume of 15.8K. Frequently Asked QuestionsIs Leverage Shares 100% TSLA AND 100% SPCX Daily ETF publicly traded?
Yes, Leverage Shares 100% TSLA AND 100% SPCX Daily ETF is publicly traded.
What exchange does Leverage Shares 100% TSLA AND 100% SPCX Daily ETF trade on?
Leverage Shares 100% TSLA AND 100% SPCX Daily ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Leverage Shares 100% TSLA AND 100% SPCX Daily ETF?
The ticker symbol for Leverage Shares 100% TSLA AND 100% SPCX Daily ETF is ELOL on the Nasdaq Stock Market
What is the current price of Leverage Shares 100% TSLA AND 100% SPCX Daily ETF?
The current price of Leverage Shares 100% TSLA AND 100% SPCX Daily ETF is 23.02
When was Leverage Shares 100% TSLA AND 100% SPCX Daily ETF last traded?
The last trade of Leverage Shares 100% TSLA AND 100% SPCX Daily ETF was at 10/15/26 03:18 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|